- Home
- OPTX vs INMB Comparison
OPTX vs INMB Comparison
Compare OPTX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTX
- INMB
- Stock Information
- Founded
- OPTX 1981
- INMB 2015
- Country
- OPTX United States
- INMB United States
- Employees
- OPTX N/A
- INMB N/A
- Industry
- OPTX Blank Checks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- OPTX Finance
- INMB Health Care
- Exchange
- OPTX Nasdaq
- INMB Nasdaq
- Market Cap
- OPTX 62.0M
- INMB 68.9M
- IPO Year
- OPTX N/A
- INMB 2019
- Fundamental
- Price
- OPTX $1.48
- INMB $1.95
- Analyst Decision
- OPTX
- INMB Buy
- Analyst Count
- OPTX 0
- INMB 4
- Target Price
- OPTX N/A
- INMB $9.53
- AVG Volume (30 Days)
- OPTX 121.7K
- INMB 806.4K
- Earning Date
- OPTX 09-19-2025
- INMB 10-30-2025
- Dividend Yield
- OPTX N/A
- INMB N/A
- EPS Growth
- OPTX N/A
- INMB N/A
- EPS
- OPTX 0.00
- INMB N/A
- Revenue
- OPTX $29,392,186.00
- INMB $50,000.00
- Revenue This Year
- OPTX N/A
- INMB $142.83
- Revenue Next Year
- OPTX N/A
- INMB $14,780.90
- P/E Ratio
- OPTX $901.03
- INMB N/A
- Revenue Growth
- OPTX 4.00
- INMB N/A
- 52 Week Low
- OPTX $0.85
- INMB $1.86
- 52 Week High
- OPTX $5.10
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- OPTX 44.56
- INMB 32.96
- Support Level
- OPTX $1.47
- INMB $1.94
- Resistance Level
- OPTX $1.69
- INMB $2.44
- Average True Range (ATR)
- OPTX 0.13
- INMB 0.13
- MACD
- OPTX -0.00
- INMB 0.01
- Stochastic Oscillator
- OPTX 20.59
- INMB 13.10
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.